Not connected to GLP3Planner: GLP3Planner has no connection to “GLP3-B” capsules or any shop selling them through social media ads. We don't sell medication, supplements or peptides and never take orders. For an order or refund, contact the seller or your bank or card provider.

Planner

Retatrutide Injection Site Rotation Planner

Enter your start date, the day you inject and the body areas you use. The planner gives you a dated site for every reta injection, shows how long before each spot comes round again, and lets you copy the plan or add it to your calendar.

No label: Retatrutide is investigational and has no FDA-approved label or instructions for use. Lilly's injection-site study (NCT05959096) gave it under the skin of the thigh, upper arm or abdomen. This planner lays out the areas you choose on your dates; it does not recommend a site.

Your first injection in this plan

Leave it empty to start today.

Injection Days

The day or days you inject each week

📍 Areas You Use

Tap every area you rotate through

Spots in Each Area

Different spots you use inside one area

🔄 Rotation Order

Only differs with 2 or more spots per area

doses
site rotation
Next Injection Injection 1
Site Abdomen, left side
Same Spot Again 28days later (every 4 injections)
Same Area Again 28days later
Plan Ends Injection 12

Once a week across 4 areas, each spot comes round again every 4 weeks (28 days). Add your start date to see the dates.

Your injection site schedule

Example: once a week, 4 areas, one spot each. The planner fills in your own dates.

# Date Site Same spot last used
1 Week 1 Abdomen, left side First use in plan
2 Week 2 Abdomen, right side First use in plan
3 Week 3 Left thigh First use in plan
4 Week 4 Right thigh First use in plan
5 Week 5 Abdomen, left side 28 days earlier
6 Week 6 Abdomen, right side 28 days earlier
7 Week 7 Left thigh 28 days earlier
8 Week 8 Right thigh 28 days earlier

Where retatrutide was injected in Lilly's injection-site study

Retatrutide has no FDA-approved label or instructions for use, so there is no label to quote. Lilly's injection-site study compared absorption from the upper arm and thigh with the abdomen. Its record says:

"LY3437943 administered subcutaneously (SC) in either thigh, upper arm, or abdomen"

Source: ClinicalTrials.gov NCT05959096, Eli Lilly and Company. Completed July 2024; no results posted as of 29 October 2026.

For comparison only, not as retatrutide instructions: the labels of two approved medicines, Zepbound (tirzepatide) and Wegovy (semaglutide), name the same three areas and both say "Rotate injection sites with each dose" (Zepbound section 2.4, Wegovy section 2.1). The Zepbound label adds that "another person should inject in the back of the upper arm". The tirzepatide and semaglutide planners quote those labels in full.

Quick answer: Retatrutide has no FDA-approved label; its injection-site study used the thigh, upper arm and abdomen. Once a week across 4 areas (left and right abdomen, left and right thigh), each spot comes round again every 4 weeks. Enter your own start date, days and areas above to get your dated plan.

How the planner builds your rotation

The planner lists the areas you tick in a fixed order (abdomen left and right, then thighs, then upper arms) and repeats that list for as many injections as you plan. It puts each injection on the next day you inject, starting on the first of your injection days on or after your start date. If you have already started rotating, choose the last spot you used and the plan picks up from the next one.

With one spot per area, the two rotation orders give the same plan. With two or more spots per area, New area each injection moves to a different area every time and uses the next spot when it returns, while Finish one area, then move uses every spot in one area, one injection each, before moving to the next area. Either way, every spot is used once before any spot repeats, so the number of days before the same spot comes back is the same; only how often you return to the same area changes.

How often each spot comes back (once a week)

Areas 1 spot each 2 spots each 3 spots each 4 spots each
2 2 weeks (14 days) 4 weeks (28 days) 6 weeks (42 days) 8 weeks (56 days)
4 4 weeks (28 days) 8 weeks (56 days) 12 weeks (84 days) 16 weeks (112 days)
6 6 weeks (42 days) 12 weeks (84 days) 18 weeks (126 days) 24 weeks (168 days)

Weeks between two injections at the same spot: the number of spots in the rotation (areas times spots per area), one injection a week. These are counts, not a recommended rest period. If you inject more than once a week, the planner works out the days for your own schedule.

What this planner does not do

It does not choose your sites, tell you which area is best, or set your dose or dosing days. It lays out the areas and days you enter. It cannot see your skin: if a spot is sore, bruised or damaged on the day, use the "Last spot you used" box to restart the plan from wherever you injected. Retatrutide has no FDA-approved label or instructions for use. Always consult a licensed healthcare provider. See the retatrutide injection sites guide for how to inject at each area.

Frequently asked questions

Where can you inject reta?

Retatrutide is investigational and has no FDA-approved label or instructions for use. Lilly's injection-site study (NCT05959096) gave it under the skin of the thigh, upper arm or abdomen (the study record: "LY3437943 administered subcutaneously (SC) in either thigh, upper arm, or abdomen"). The Zepbound (tirzepatide) and Wegovy (semaglutide) labels name the same three areas (sections 2.4 and 2.1). This planner rotates through whichever of those areas you choose.

How do you rotate reta injection sites?

There is no FDA-approved retatrutide label to set a rotation rule. The Zepbound and Wegovy labels both say "Rotate injection sites with each dose" (sections 2.4 and 2.1). Enter your start date, injection day and the areas you use, and the planner gives a site for every injection date, cycling through every spot before it repeats one.

Can you inject reta into your own upper arm?

Retatrutide has no FDA-approved label or instructions for use. For comparison, the label of Zepbound (tirzepatide, also made by Lilly) says "another person should inject in the back of the upper arm" (section 2.4). The planner leaves the upper arm unticked until you add it.

How long before the planner brings me back to the same spot?

It depends on how many areas and spots you rotate through and how often you inject. Once a week across 4 areas with one spot each, the same spot comes back every 4 weeks (28 days); keeping 2 spots in each area doubles that to 8 weeks. The planner shows the exact number of days for your own schedule. These are counts, not a recommended rest period.

Safety: Retatrutide is an investigational compound and is not approved by the FDA. This tool is educational only. It lays out the sites you choose on the dates you enter; it does not recommend an injection site, a dose or a dosing schedule. Always consult a licensed healthcare provider about your treatment.

i How to Use

Pick your start date and the day you inject, then tap the areas you rotate through. Add spots per area if you use more than one spot inside each area.

The dated plan updates instantly. Copy it, or download the .ics file to add every injection to your phone calendar.

ii About Rotation

Retatrutide has no FDA-approved label to set a rotation rule. For comparison, the Zepbound and Wegovy labels both say "Rotate injection sites with each dose."

Disclaimer: This planner is for educational purposes only. It lays out the sites and days you enter and does not recommend an injection site, dose or schedule. Always consult a licensed healthcare provider about your treatment.